Addiction

International Medicine in Addiction Conference

17 February 2023

Melbourne

Australia

International Medicine in Addiction (IMiA) Conference

17-19 February 2023, Melbourne, Australia.

IMiA 2023 program will be two and a half day program, showcasing international and local professionals. Throughout the program common themes will be intertwined.

keynote speakers

workshop sessions

EU Early Warning System on NPS- Poster

Poster

Summary This poster, presented during the IX International Conference on NPS(24 to 26 Oct 2022, Panama), showcases some of the work of the EU Early Warning System on new psychoactive substances. Operated by the EMCDDA, in close cooperation...

Recreational use of nitrous oxide — a growing concern for Europe

10 November 2022

Summary The purpose of this report is to examine the current situation, risks and responses to the recreational use of nitrous oxide in Europe. To support this, the report also provides a state-of-the-art review of the chemistry...

Correction: Interdisciplinary collaboration in the treatment of alcohol use disorders in a general hospital department: a mixed-method study

Scientific article

12 August 2022

Background Interdisciplinary collaborations (i.e., where various disciplines work coordinated and interdependently toward shared goals) are stated to yield higher team effectiveness than multidisciplinary approaches (i.e., where various...

Understanding injecting drug use in Afghanistan: A scoping review

Scientific article

Background Several reports have described a growing prevalence of illicit drug use in Afghanistan, with recognition of a recent shift from traditional modes of consumption involving inhalation and oral ingestion to injecting drug use...

Correlates of treatment engagement and client outcomes: results of a randomised controlled trial of nabiximols for the treatment of cannabis use disorder

Scientific article

8 October 2022

Introduction and aims There is increasing interest and evidence for the use of cannabinoid medications in the treatment of cannabis use disorder, but little examination of the correlates of successful treatment. This paper is a secondary...

Disruptions to U.S. local public health’s role in population-based substance use prevention and response during COVID-19

Scientific article

13 October 2022

Background The COVID-19 emergency has tested the public health, medical, and public safety infrastructure of the United States (U.S.) in unprecedented ways. As the focal point for public health in their communities, local health departments...

Integrated brief interventions for noncommunicable disease risk factors in primary care: the manual

Book

Abstract Brief interventions are recognized by WHO as an effective measure to help people quit tobacco, reduce or stop alcohol use and increase physical activity. They can also help to achieve and maintain healthy eating behaviours and...

Civil Society Consultation - UNODC Synthetic Drug Strategy

8 December 2022

hybrid

Pour répondre au formulaire en français, veuillez cliquer sur le bouton de langue dans le coin supérieur droit et sélectionner la langue de votre choix.
Para responder el formulario en español, haga clic en el botón de idioma en la esquina superior derecha y seleccione el idioma de su elección.
Чтобы ответить на форму на русском языке, нажмите кнопку языка в правом верхнем углу и выберите язык п

Mortality and life-years lost following subsequent physical comorbidity in people with pre-existing substance use disorders: a national registry-based retrospective cohort study of hospitalised individuals in Czechia

Scientific article

3 November 2022

Summary Background Substance use disorders constitute a major global public health problem, attributable largely to their subsequent comorbidity with other health conditions. This study aimed to investigate the risk of all-cause death and...